Slightly Higher Times: Biden Administration Moves To Loosen Weed Restrictions

The Biden administration’s Department of Health and Human Services is recommending that the Drug Enforcement Administration significantly loosen federal restrictions on marijuana but stopped short of advising that it should be entirely removed from the Controlled Substances Act.

Read More

California Pharmacies Are Making Millions Of Mistakes. They’re Fighting To Keep That Secret

California pharmacies, including those owned by big chains, make an estimated 5 million errors a year — but they’re not required to report them to state regulators.

Read More

Pharmaceutical Industry Rips ‘Draconian’ Price Negotiation Provision

The Biden administration and federal regulators may be taking a victory lap following the unveiling of the Centers for Medicare & Medicaid Services’ (CMS’) price negotiations list, but major players in the pharmaceutical industry feel the White House overstepped and think innovation will be stifled, ultimately leading to the creation of fewer life-changing drugs. Tuesday, CMS ...

Read More

Biden Administration Expects To Win Fight Over Medicare Drug Negotiations

White House domestic policy adviser Neera Tanden said Sunday that she’s convinced that the Inflation Reduction Act’s Medicare drug price negotiation program will be upheld in court. Speaking on “The Katie Phang Show” on MSNBC, Tanden said, “There is nothing in the Constitution that stops Medicare from negotiating drug prices. We really, we feel very ...

Read More

Humana Sues Feds Over Medicare Advantage Risk Adjustment Changes

Humana has filed suit against the feds, saying the Biden administration’s bid to claw back overpayments in Medicare Advantage (MA) is built on “shifting justifications and erroneous legal reasoning.” Earlier this year, the Centers for Medicare & Medicaid Services (CMS) finalized a hotly anticipated rule that would overhaul risk adjustment data validation (RADV) audits, which determine whether ...

Read More

US Lab Tests Suggest New COVID-19 Variant BA.2.86 May Be Less Contagious And Less Immune-Evasive Than Feared

Two teams of US scientists have completed lab experiments testing the antibodies from vaccinated and infected Americans to see how well they might be able to fend off currently circulating variants of the virus that causes Covid-19, including the highly mutated BA.2.86. Their results match up almost exactly, and the news – at least when ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square